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Dihydroi’ohttc rcductaac (EXiPR) ir an intrttccllulur tnrpt cnzytne fc~r klrtc anttipnixt drugo, including mcthutrctxarc. In order to compare the 
binding of mcthotrcxatc tQ human l3HFR in solution with that observed in tks eryatallinc gttttc, NMW rpetroreapy hcs been urcd to dctcrminc 
the conformation of the drug bound to human BkfPR in nolutian, In agrccmcnt with what has &XI o,blrcrvcd in ~hc eryxtrllinc xtatc, NOE’a identi- 
fied pratcin nnd mcthotrcxgtc pratonx indicate that methatrrxute binds in :I n~nqMxluctivc oricntntion. In contrast to Mar hrr been reported 
fbr E. err/l RHPR in solution, only ON bound eonrormatian af methotrcxato is observed, 
DihydrofWte rcductaoc; Protein NMR; Protein-drug interaction; Mcthotrcxatc 
1, INTRODUCTION bond. This observation is consistent with structural 
studies of DHFR from bacterial [S-9] and other mame 
Dihydrofolate rcductasc (5,6,7,8-retrafrydrofolate: malian [lOI sources, The question as to whether or not 
NADP’ oxidoreductase, EC 1.5,1.3) catalyzes rhc methotrexate binds precisely the same in ari enzyme 
NADFH-dependent reduction of 7,8-dihydrofolate to complex in the crystalline vs the solution state has been 
5,6,7,$-tetrahydrofolare. Tetrahydrofolate or its dcri- addressed, Solution NMR spectroscopy studies 
vatives are essential co-factors in the biosynthesis of reported herein confirm that methotrexate binds to 
purinc nucleotides, thymidylate and several amino human DHFR in a single non.productive orientation, 
acids. Failure to maintain adequate levels of tetra- similar to that in the crystalline state. 
hydrofolate reduces cellular thymidylate and purine 
levels, resulting in decreased nucleic acid synthesis 111. 
Based on this metabolic onsequence, DI-IFR is a phar- 
2, MATERIALS AND METHODS 
macologically important intracellular target enzyme for Recombinant human DHFR was prepared as previously described 
a number of folate antogonists, including the an- [II], Samples for NMR spectroscopy typically contained l-2 mM 
ticancer drug methotrexate and the antibacterial agent protein and 25 mM KCI in 50 mM phosphate buffer at pfj 6,S, 
trimethoprim, Recently, pneumocystis, DHFR h,as 
Samples dissolved in ‘Hz0 were prepared by repeatedly concentrating 
the solution under a stream of nitrogen gas and adding ‘HzO, Phase- 
become an important anti-folate target since pneumo- sensitive NOESY [12] and DQFCOSY [13] spectra were recorded on 
cystis infection is the main cause of death in patients a GF1-500 spectrometer at 298K. Dato were processed using the pro- 
with acquired immunodeficiency syndrome [2] I gram FELIX from Hare Research, Inc. Proton chemical shifts were 
Crystallographic studies of human DHFR indicate 
referenced to the ‘HDO signal at 4.76 ppm, 
that substrate folate,and inhibitor methotrexate bind in 
different conformations [3,4]. Whereas folate binds in 
a stereochemically correct orientation for reduction, 
3. RESULTS 
methotrexate binds in a non-productive orientation Resonances of bound methotrexate protons were 
with the pteridine ring rotated by 1 80° about the C6-C9 distinguished from those of the protein and assigned 
using the foilowing strategy. In Fig. 1, NOE’s are 
Correspondence address: G. Wagner, Department of Biological observed correlating to a resonance at 7.91 ppm. The 
Chemistry and Molecular Pharmacology, Harvard Medical School, relative sharpness of this resonance suggests that it is 
240 Longwood Avenue, Boston, MA 02115, USA not scalar coupled to other protons. That this resonance 
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enhancement; NOESY, nuclear Overhauser enhancement spec- 
troscopy 
is not from ths polypeptide is proven by the fact that it 
does not give rise to a *H-13C or ‘H-“N cross peak in 
heteronuclear correlation spectra of 13C/15N doubly- 
labeled polypeptide complexed with unlabeled 
Published by Elsevier Science Publishers B. V. 267 
Fig. I. k&ions of the 100 ms NQESY (above the diagonal) and DQF-COSY (below the diagonal) rpcctra of human 
to the mrthofrcxatc l-17 resonance are indicated, 
DHFR in IQO% ‘HzO, NOE’s 
methocrexatc (data not shown), This resonance is thus 
assigned to H7 of the pteridine ring of methotrcxatc. 
The benzoyl moiety of mcthotrexate is manifested in 
the DQF-COSY spectrum by a correlation between the 
H12/16 (7,33 ppm) and H13/15 (6.15 ppm) protons. 
They are distinguished by virtue of an NOE between the 
H7 and H 13/l 5 protons, as indicated in Fig. 1. As 
shown in,Fig, 2, both the H7 and H13/15 protons have 
an NOE to a resonance at 3.39 ppm, which is thereby 
assigned to the methyl group on NlO, The NlO methyl 
group has additional NOE’s to resonances at 4.48 and 
5.11 ppm (not shown), which are assigned to the 
‘methotrexate PI9 protons. 
, -- 
B- 
Fig. 1 indicates two other aromatic NQE’s to the 
methotrexate H7 resonance. These two resonances arise 
from the c- and {-protons of a phenylalanine spin 
system, delineated in the lower part of Fig. 1. In Fig. 2, 
NOE’s are observed from the H7 proton to two 
resonances at high field. Heternonuclear three- 
dimensional NMR spectroscopy [ 14,151 of uniformly 
15N-labeled human DHFR has permitted assignment of 
more than 90% of the polypeptide (unpublished 
Fig. 2, Region of the 100 ms NOESY spectrum of human DHFR 
showing interactions from the methotrexate H7 and H13/15 protons 
to atiphatic protein and methotrexate protons. 
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